C hronic low back pain continues to be one of the conditions most commonly presenting to orthopedic surgeons, who, following primary practitioners, are the most common physicians patients seek. 1, 2 It is the fifth most frequent indication for a physician visit. 2 Up to 85%
of the population will experience an episode of nonspecific low back pain during their lifetimes, but the vast majority (more than 90%) will have a self-limited disease that resolves within 3 months. 1, 3, 4 However, due to the large number of patients presenting with this condition annually, it represented a substantial fiscal burden estimated to be $26 billion in 1998 and nearly $100 billion in 2007. 5, 6 Chronicity is less common, but the prevalence of chronic low back pain in the United States rose from 3.9% in 1992 to 10.2% in 2006. 7, 8 These patients in particular may be drivers of cost because they often require substantial medical intervention and have high pharmacologic costs. 5, 9 Low back pain is associated with substantial direct (eg, cost of medical care) and indirect (eg, lost productivity due to time off work) costs. A study of Swedish patient data by Ekman et al 10 demonstrated that direct costs represented only 15% ($2200) of the total annual cost, with 85% ($16,600) consisting of indirect costs.
Patients with chronic low back pain who do not also have neurological deficits represent a treatment dilemma with multiple nonoperative treatment modalities proposed. 11 However, combined guidelines from the American College of Physicians and the American Pain Society, 12 which were also adopted by the American Academy of Orthopaedic Surgeons in 2010, 13 have given nonoperative modalities a weak recommendation due to the poor level of evidence for the supporting studies. One potential treatment modality for chronic low back pain is transcutaneous electrical nerve stimulation (TENS). This functions by delivering a localized voltage of varying intensity and frequency, which has been shown to inhibit normal nociceptive fiber signaling. [14] [15] [16] The literature has reported mixed results regarding the efficacy of TENS. Recent meta-analyses by Brosseau n tips & techniques evidence for or against the use of this treatment modality. The primary reason for this lack of consensus is interstudy heterogeneity, which is due to a lack of a standardized treatment protocol (eg, different TENS device settings, duration of treatments, and adjuvant therapies). 19, 20 However, no study has evaluated the clinical and economic effects of the use of TENS for the treatment of chronic low back pain without neurological symptoms using a nationwide administrative claims database.
The purpose of this study was to evaluate the clinical and economic effects among patients who were given TENS for chronic low back pain compared with a matched group of patients who were not given TENS, both prior to intervention and at 1-year follow-up. The primary outcome measures of this study were whether the use of TENS resulted in differences between (1) hospital and clinic visits; (2) use of diagnostic imaging; (3) use of physical therapy; (4) incidence of back surgery; and (5) treatment costs.
Materials and Methods
The costs and clinical effects of TENS for patients with chronic low back pain, compared with those who were not treated with TENS, were evaluated using a commercial and Medicare supplemental administrative claims database (MarketScan; Truven Health Analytics, Ann Arbor, Michigan). This database contained claims and eligibility records for approximately 30 million enrollees in distinct sets of files for commercially insured individuals (ie, working-aged adults and their dependents), and 3 million enrollees for Medicare supplemental insurance. Patients were selected if they had at least 2 ICD-9-CM coded claims for low back pain during a 3-month period anytime between January 1, 2008, and September 30, 2010. Patients were then divided into groups based on those who received TENS and those who did not receive TENS during the follow-up period ( Table  1) . For TENS patients, the date of the first TENS procedure was set as the study index date. The index date for the non-TENS patients was the date of the first claim for procedures other than TENS (eg, physical therapy, opioids, back surgery, or diagnostic imaging).
Patients in each group were matched using a 1:1 greedy propensity score matching algorithm to ensure patient groups were comparable regarding baseline clinical and demographic characteristics. Logistic regression models were used to calculate a predicted probability of group membership (eg, receiving TENS vs not receiving TENS), or propensity score, based on the observed predictors. The following variables were included in the logistic regression model: age, sex, geographic region of residence, indicators of individual comorbidities, medication use, back surgery, and surrogate low back pain baseline severity measures. These predictor variables were measured during the 12-month pre-index period. Following matching, there were 22,913 patients in each group (Figure) . Patients with low back pain findings without neurological involvement were further selected using ICD-9 diagnosis codes to isolate patients with purely mechanical low back pain (as opposed to patients with neurological symptoms or those with congenital or acquired spinal disorders). After final selection, there were 16,593 patients available for analyses.
Primary outcomes (hospital and clinic visits; physical therapy use; incidence of back surgery; direct and indirect treatment costs) were compared across treatment groups by measuring the proportion of patients with an outcome for categorical variables (eg, n tips & techniques percent of patients having outpatient or inpatient visits) or the means for continuous variables (eg, total medical costs). All outcomes were evaluated at baseline (prior to intervention) and at 1-year follow-up. All statistical analyses were performed using SAS version 9.1 software (SAS, Cary, North Carolina). The chance of having a type I error used as a cutoff to determine statistical significance was set at alpha=0.05. Continuous study measures were assessed and reported with means and SDs. Categorical variables were reported using frequency distributions. Student's t test was used to test for statistical differences for continuous variables, chi-square test was used for categorical variables, and the nonparametric Wilcoxon rank sum test was used for ranked data.
results
Baseline demographic and clinical variables were compared between TENS and non-TENS patients. There were no significant differences between the 2 groups based on mean age, age category, sex, geographic region of residence, major medical comorbidities, Charlson Comorbidity Index, or psychiatric disorders ( Table   2 ). The only significant differences observed were in the type of insurance (13.1% in the TENS group had supplemental Medicare insurance compared with 11.9% in the non-TENS group) and single episodes of low back pain (17.6% vs 16.4%, respectively) (Tables 2-3 Table 5) .
Overall Cohort
Diagnostic imaging use during the 1-year follow-up period was found to be significantly lower in TENS patients (mean, 31 events per 100 patients) Physical therapy use at 1-year follow-up was significantly lower in TENS patients (mean, 94 events per 100 patients) compared with non-TENS patients (mean, 107 events per 100 patients; P<.0001). Of note is that the higher number demonstrates that several patients were prescribed physical therapy on more than 1 occasion.
Similar trends were seen in back surgery. An evaluation of the entire cohort demonstrated significantly less back surgery in TENS patients (mean, 7.5 episodes per 100 patients) compared with non-TENS patients (mean, 9.2 episodes per 100 patients; P<.0001).
discussion
The purpose of this study was to evaluate resource use and costs in patients with chronic low back pain who received TENS compared with a matched group of patients with chronic low back pain who did not receive TENS. Few studies have evaluated the effect of TENS use or non-use on resource use and costs using a large administrative claims database. 21 The current authors observed that TENS was associated with significantly fewer inpatient visits and less diagnostic imaging, physical therapy, and back surgery. Overall, when all costs were considered, TENS use was cost neutral compared with TENS non-use, although the upfront costs for the unit itself were significantly higher.
Avoiding surgery when it is not clinically indicated is of utmost importance to orthopedic surgeons. However, this may be particularly difficult when patients erroneously believe that surgery in the setting of no neurologic compromise will effectively reduce their pain. Spinal fusion to treat chronic low back pain is controversial, with conflicting data on clinical and disability outcomes. In a randomized, controlled trial performed in Norway comparing surgical outcomes with physical therapy and cognitive intervention for 124 patients with chronic low back pain (symptom duration, more than 1 year) but no neurological symptoms, Froholdt et al 22 observed no difference in clinical outcome scores at 9-year followup (mean adjusted Oswestry Disability Index treatment effect, 1.9; 95% confidence interval, -7.9 to 11.6). The authors also observed that, compared with prior studies reporting 1-and 4-year followup, there was no significant difference in disability, pain, fear avoidance beliefs, trunk muscle strength, and return to work for lumbar fusion compared with structured exercise and cognitive behavioral therapy for treatment of chronic low back pain. [23] [24] [25] Therefore, the current study provides a potentially compelling treatment alternative and/or adjuvant for patients for whom back surgery is not indicated. The current authors observed that TENS was a noninvasive option that provided clinical and economic advantages compared with non-use of TENS. Interestingly, in the entire cohort, which included patients with neurological symptoms, TENS was observed to result in less back surgery.
The observed reduction in the use of medical imaging and opioids for TENS patients with chronic low back pain is in stark contrast to increases in imaging studies and opioid therapy during the past 12 Although the current study could not definitively determine the circumstances for imaging in each patient, the observation that fewer imaging studies were done for TENS patients with chronic low back pain is an important factor contributing to lower overall health care costs. Likewise, in the current study, the small reduction in opioid use for TENS patients with chronic low back pain may be important as an overall public health measure in reducing the exposure of chronic low back pain patients to chronic opioid use and the related sequelae. According to the jointly issued American College of Physicians and American Pain Society guidelines, "Failure to respond to a time-limited course of opioids should lead to reassessment and consideration of alternative therapies or referral for further evaluation." 12 Alternative therapies such as TENS for chronic low back pain may provide clinicians with an option that requires less imaging and avoids opioid pain medication in this challenging population.
There were several limitations to this study. First, confounding factors may have occurred as a result of selection bias related to receiving the 27 attempted to evaluate the cost-effectiveness of several treatments for chronic low back pain but identified few reports of high quality. This general lack of available data should be seen as an opportunity to further understand the interplay between efficacy and cost-effectiveness in the treatment of chronic low back pain that is likely due to heterogeneous causes.
On the basis of the current study, the authors believe that TENS may be a useful adjuvant in the management of chronic low back pain, which may be more difficult to manage than new-onset acute low back pain. Compared with 
